Mara Aspinall is the Co-Founder and Managing Director of BlueStone Venture Partners. See contact routes.
Mara Aspinall is the Co-Founder and Managing Director of BlueStone Venture Partners, a life sciences firm she established in 2017 with Tom Nickoloff in Tucson, Arizona, drawing on her prior experience as CEO of Ventana Medical Systems and a strategic consultant at Bain & Company. Her investment thesis targets early-stage life science companies, specifically focusing on Series A and B rounds in Medical Devices, Diagnostics, Digital Health, and Life Science Research Tools outside traditional US innovation hubs, with a primary geographic concentration in the Southwest United States. While specific check sizes for Aspinall individually are not detailed, the firm provides growth capital for rounds such as a recent $23.0 million Series A in Predicta Biosciences, and she has served as the lead partner on five deals. Notable portfolio companies include Paradigm Diagnostics, where she joined the Board of Directors following a $15 million Series B extension, as well as GT Medical Technologies and BroadSpot Imaging Corporation. Aspinall distinguishes her approach by heading the Health Catalysts Group, which publishes the annual Health Catalysts Diagnostics Year
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Tucson when building a target list.
Investors like Mara Aspinall · Full investor directory · Investor access · Company funding database